Published in J Am Coll Cardiol on December 24, 2013
PARP-1 Inhibition in Pulmonary Arterial Hypertension | NCT03251872
Pulmonary Hypertension in Haemodialysis Patients :Frequency and Risk Factors | NCT03310229
Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study (APPRoAcH-p) | NCT03655704
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respir Crit Care Med (2014) 2.23
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia. Am J Respir Crit Care Med (2014) 1.73
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension. Am J Respir Crit Care Med (2015) 1.58
Bone Morphogenetic Protein Receptor Type II Deficiency and Increased Inflammatory Cytokine Production. A Gateway to Pulmonary Arterial Hypertension. Am J Respir Crit Care Med (2015) 1.53
Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS One (2014) 1.51
Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report. Chest (2014) 1.44
Riociguat for pulmonary arterial hypertension associated with congenital heart disease. Heart (2015) 1.44
Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension. Pulm Circ (2016) 1.43
Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders. J Heart Lung Transplant (2014) 1.41
Identification of Rare Variants in ATP8B4 as a Risk Factor for Systemic Sclerosis by Whole-Exome Sequencing. Arthritis Rheumatol (2016) 1.41
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects. Hum Mutat (2015) 1.38
Imatinib relaxes the pulmonary venous bed of guinea pigs. Respir Res (2017) 1.38
Clinical manifestations of sleep apnea. J Thorac Dis (2015) 1.25
An international physician survey of pulmonary arterial hypertension management. Pulm Circ (2016) 1.23
Pulmonary hypertension of sickle cell disease beyond classification constraints. J Am Coll Cardiol (2014) 1.09
Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc (2014) 1.08
Inflammatory cytokines in pulmonary hypertension. Respir Res (2014) 1.03
Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial. J Clin Oncol (2016) 1.03
Left ventricular dysfunction in patients with suspected pulmonary arterial hypertension. J Bras Pneumol (2015) 1.02
Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulm Circ (2015) 1.01
The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension. Am J Respir Cell Mol Biol (2014) 0.98
Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism. Circulation (2015) 0.98
Echocardiographic Diagnosis of Acute Pulmonary Embolism in Patients with McConnell's Sign. Echocardiography (2015) 0.97
Current clinical management of pulmonary arterial hypertension. Circ Res (2014) 0.96
Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: results from two institutions. Magn Reson Med (2014) 0.96
Obesity paradox in group 1 pulmonary hypertension: analysis of the NIH-Pulmonary Hypertension registry. Int J Obes (Lond) (2017) 0.96
The genetics of pulmonary arterial hypertension. Circ Res (2014) 0.95
Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension. EMBO Mol Med (2015) 0.95
Left ventricular heart failure and pulmonary hypertension†. Eur Heart J (2015) 0.95
Right ventricular adaptation and failure in pulmonary arterial hypertension. Can J Cardiol (2015) 0.94
The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. Am J Physiol Lung Cell Mol Physiol (2014) 0.94
Loss of microRNA-17∼92 in smooth muscle cells attenuates experimental pulmonary hypertension via induction of PDZ and LIM domain 5. Am J Respir Crit Care Med (2015) 0.93
Rationale and design of the Pan African Pulmonary hypertension Cohort (PAPUCO) study: implementing a contemporary registry on pulmonary hypertension in Africa. BMJ Open (2014) 0.91
Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension. J Appl Physiol (1985) (2015) 0.91
Smooth muscle cell progenitors are primed to muscularize in pulmonary hypertension. Sci Transl Med (2015) 0.90
Balloon Pulmonary Angioplasty: A Treatment Option for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension. Front Cardiovasc Med (2015) 0.90
MicroRNAs in pulmonary arterial hypertension. Am J Respir Cell Mol Biol (2015) 0.90
The molecular targets of approved treatments for pulmonary arterial hypertension. Thorax (2015) 0.90
Mitochondrial dynamics in pulmonary arterial hypertension. J Mol Med (Berl) (2015) 0.89
Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model. Stem Cells Int (2014) 0.87
Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration. Free Radic Biol Med (2015) 0.87
The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension. Am J Respir Crit Care Med (2015) 0.86
Reversible pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis. Can Respir J (2015) 0.86
Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients. Kidney Res Clin Pract (2015) 0.86
Peripheral pulmonary artery stenosis as a cause of pulmonary hypertension in adults. Pulm Circ (2015) 0.86
Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options. Clin Res Cardiol (2014) 0.86
Neonatal hyperoxic lung injury favorably alters adult right ventricular remodeling response to chronic hypoxia exposure. Am J Physiol Lung Cell Mol Physiol (2015) 0.84
Pulmonary arterial hypertension exacerbated by ruxolitinib. Haematologica (2015) 0.84
Pulmonary hypertension: diagnostic and therapeutic challenges. Ther Clin Risk Manag (2015) 0.84
Pulmonary rehabilitation and exercise in pulmonary arterial hypertension: An underutilized intervention. J Exerc Rehabil (2015) 0.84
TGF beta and IL13 in Schistosomiasis mansoni associated pulmonary arterial hypertension; a descriptive study with comparative groups. BMC Infect Dis (2014) 0.84
Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension. Am J Respir Crit Care Med (2016) 0.84
A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions. Sci Rep (2015) 0.83
Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Clin Pharmacol Ther (2014) 0.83
MR phase-contrast imaging in pulmonary hypertension. Br J Radiol (2016) 0.83
Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry. BMC Pulm Med (2014) 0.83
Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course. Ther Clin Risk Manag (2014) 0.82
Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease. Clin Med Insights Oncol (2015) 0.82
Life span of patients with Eisenmenger syndrome is not superior to that of patients with other causes of pulmonary hypertension. Cardiovasc Diagn Ther (2014) 0.82
Quality of life as a prognostic marker in pulmonary arterial hypertension. Health Qual Life Outcomes (2014) 0.82
Pulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the Literature. Front Pediatr (2015) 0.82
Pulmonary hypertension and right heart dysfunction in chronic lung disease. Biomed Res Int (2014) 0.82
Pulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Systematic review on pharmacotherapy and interventional strategies. Biomed Res Int (2014) 0.82
Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells. Mol Ther (2016) 0.82
Targeting BMP signalling in cardiovascular disease and anaemia. Nat Rev Cardiol (2015) 0.82
Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension. Ann Am Thorac Soc (2016) 0.81
HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment. AIDS Res Ther (2015) 0.81
Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009. Pulm Circ (2015) 0.81
Update in Pulmonary Vascular Diseases 2014. Am J Respir Crit Care Med (2015) 0.81
Coenzyme Q supplementation in pulmonary arterial hypertension. Redox Biol (2014) 0.81
Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension. Circulation (2016) 0.81
Treatment of pulmonary hypertension in idiopathic pulmonary fibrosis: shortfall in efficacy or trial design? Drug Des Devel Ther (2014) 0.81
Are transcutaneous oxygen and carbon dioxide determinations of value in pulmonary arterial hypertension? Microcirculation (2015) 0.81
Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension. Lung (2015) 0.81
Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant. Front Pediatr (2016) 0.81
DNA Damage and Pulmonary Hypertension. Int J Mol Sci (2016) 0.81
O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension. Circulation (2015) 0.81
Altered Right Ventricular Kinetic Energy Work Density and Viscous Energy Dissipation in Patients with Pulmonary Arterial Hypertension: A Pilot Study Using 4D Flow MRI. PLoS One (2015) 0.81
Dramatic and sustained responsiveness of pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension to vasodilator therapy. Respir Med Case Rep (2014) 0.81
Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension. Korean J Intern Med (2015) 0.81
Molecular and clinical analysis of TRPC6 and AGTR1 genes in patients with pulmonary arterial hypertension. Orphanet J Rare Dis (2015) 0.81
Pulmonary hypertension and pregnancy: the experience of a tertiary institution over 15 years. Ann Card Anaesth (2015) 0.81
Post splenectomy related pulmonary hypertension. World J Respirol (2015) 0.81
N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats. Respir Res (2014) 0.81
The right ventricle and pulmonary hypertension. Heart Fail Rev (2016) 0.80
Left ventricular diastolic dysfunction in pulmonary hypertension predicts functional capacity and clinical worsening: a tissue phase mapping study. J Cardiovasc Magn Reson (2015) 0.80
Comparison between the Acute Pulmonary Vascular Effects of Oxygen with Nitric Oxide and Sildenafil. Front Pediatr (2015) 0.80
Chronic Thromboembolic Pulmonary Hypertension: A Worldwide View of How Far We Have Come. Lung (2016) 0.80
Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers. Pulm Circ (2015) 0.80
Animal Models of Pulmonary Hypertension: Matching Disease Mechanisms to Etiology of the Human Disease. J Pulm Respir Med (2014) 0.80
Molecular pathogenesis and current pathology of pulmonary hypertension. Heart Fail Rev (2016) 0.80
Pathophysiology and treatment of pulmonary hypertension in sickle cell disease. Blood (2016) 0.80
A case of interferon-α-induced pulmonary arterial hypertension after living donor liver transplantation. Heart Vessels (2015) 0.80
An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research. Am J Respir Crit Care Med (2016) 0.79
Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients. Medicine (Baltimore) (2016) 0.79
Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease. Pulm Circ (2016) 0.79
Echocardiographic findings associated with mortality ortransplant in patients with pulmonary arterial hypertension:A systematic review and meta-analysis. Neth Heart J (2016) 0.79
Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of View. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2015) 0.79
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol (2015) 0.79
Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension. Pulm Circ (2015) 0.79